Latest Articles

Breast Cancer Breast Cancer: Determining the Best Diet for Disease Prevention

Breast Cancer: Determining the Best Diet for Disease Prevention

Higher ERDP scores were significantly associated with developing breast cancer.

Renal Cell Carcinoma Does Sunitinib Have A Future in Renal Cell Carcinoma Treatment?

Does Sunitinib Have A Future in Renal Cell Carcinoma Treatment?

Immunotherapy may supplant sunitinib in RCC, except for in patients who cannot tolerate checkpoint inhibition.

Breast Cancer Widening the Use of Preventive Therapies Against Breast Cancer

Widening the Use of Preventive Therapies Against Breast Cancer

Preventive treatments are strongly recommended in women with AH and LCIS.

Chronic Lymphocytic Leukemia Infections: A Cause for Concern Among Patients With CLL

Infections: A Cause for Concern Among Patients With CLL

Patients with CLL may have both disease-associated and systemic treatment-associated immune dysfunction, leaving them vulnerable to infection.

General Oncology HIV-Associated Cancers: A Paradigm Shift?

HIV-Associated Cancers: A Paradigm Shift?

Many HIV-associated cancers develop with the help of oncoviruses — some of which are sexually transmitted.

Side Effect Management Late-Onset Toxicity Possible With Immunotherapy

Late-Onset Toxicity Possible With Immunotherapy

Postapproval studies are needed to further characterize the risk and long-term safety of immune checkpoint inhibition.

Prostate Cancer Diet and Dosage: How Much Could Patients Save?

Diet and Dosage: How Much Could Patients Save?

Knowing that food increases the absorption of some therapies presents the possibility of easily — and significantly — lowering treatment costs.

Lymphoma Ibrutinib and Venetoclax: A New Standard for Mantle Cell Lymphoma?

Ibrutinib and Venetoclax: A New Standard for Mantle Cell Lymphoma?

Preclinical models indicated that dual inhibition of BTK and BCL2 may be synergistic.

Lymphoma Brentuximab in Classical Hodgkin Lymphoma — In the Clinic

Brentuximab in Classical Hodgkin Lymphoma — In the Clinic

Brentuximab vedotin is an anti-CD30 monoclonal antibody that targets the Reed-Sternberg cells found in patients with classical HL.

Breast Cancer Identifying the Optimal Breast Cancer Screening Interval

Identifying the Optimal Breast Cancer Screening Interval

It is unclear whether breast cancer screening — and specifically mammography — reduces the likelihood of being diagnosed with advanced-stage disease.

Prostate Cancer Preventive Benefit of Finasteride for Prostate Cancer Maintained for 16 Years

Preventive Benefit of Finasteride for Prostate Cancer Maintained for 16 Years

Results from the Prostate Cancer Prevention Trial indicate that the reduced risk for prostate cancer among men assigned to finasteride continued throughout 16 years of follow-up.

General Oncology Anticancer Immunotherapy to Circumvent Tumor Resistance to Immune Checkpoint Inhibitors

Anticancer Immunotherapy to Circumvent Tumor Resistance to Immune Checkpoint Inhibitors

Most tumors do not respond, or evolve resistance, to immune checkpoint inhibition. Now, researchers at Johns Hopkins have engineered a new class of cancer immunotherapy agents designed to short-circuit key mechanisms of tumors' disruption and evasion of immune system attack.

General Oncology Phase 1 Trials: Therapy, Not Just Science

Phase 1 Trials: Therapy, Not Just Science

Phase 1 trials should be considered therapeutic options for some patients.

Side Effect Management Immunotherapy and the Risk of Myocarditis

Immunotherapy and the Risk of Myocarditis

The risk should not discourage patients with cancer from taking these potentially life-extending therapies.

Chronic Myeloid Leukemia Identifying Treatment Failure in Patients With Chronic Myeloid Leukemia

Identifying Treatment Failure in Patients With Chronic Myeloid Leukemia

One study's results may be especially relevant for patients eligible for treatment discontinuation.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs